Pharma News Intelligence March 4, 2020
Samantha McGrail

The net and list price gap of prescription drugs continues to widen year over year as net cost rose significantly over ten years, burdening healthcare payers.

The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy Institute.

The study published in JAMA Network Open uncovered that prescription drug prices have steadily increased over the last ten years.

“Previously, we were limited to studying list prices, which do not account for manufacturer discounts. List prices are very important, but they are not the full story,” Inmaculada Hernandez, PharmD, PhD, assistant professor of pharmacy at Pitt and lead author of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Market Research, Pharma, Pricing / Spending, Provider, Trends
RFK Jr. vs. Vivek: Trump world's two paths for pharma regulation
Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025?
AI in Pharma: Where, When, and How Executives are Considering it
Grifols linked to €7bn takeover offer from Brookfield
Pharma Pulse 11/19/24: Is Any Data Better Than No Data? Exploring Emerging Vitiligo Therapies & more

Share This Article